|Bid||43.95 x 900|
|Ask||50.55 x 800|
|Day's Range||48.79 - 50.21|
|52 Week Range||43.30 - 80.92|
|Beta (3Y Monthly)||1.83|
|PE Ratio (TTM)||36.96|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
The best health care stocks to watch have several commonalities including a streak of earnings growth. It's important to keep tabs on high-ranking health care stocks with strong metrics.
Hedge fund managers like David Einhorn, Bill Ackman, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking their stock picks may provide us with significant returns as well. Many hedge funds, like Paul Singer’s Elliott Management, are pretty secretive, but we can still get some insights by analyzing […]
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on April 25) Biohaven Pharmaceutical Holding Co Ltd (NYSE: BHVN ...
On a per-share basis, the Malvern, Pennsylvania-based company said it had profit of 32 cents. Earnings, adjusted for one-time gains and costs, were 42 cents per share. The results met Wall Street expectations. ...
BioTelemetry, Inc. (NASDAQ:BEAT), which is in the healthcare business, and is based in United States, received a lot of attention from a substantial price movement on the NASDAQGS ove...
BioTelemetry (BEAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Teladoc (TDOC) teams up with Cincinnati Children's Hospital Medical Center to launch consumer pediatric telehealth platform.
In the latest trading session, BioTelemetry (BEAT) closed at $60.03, marking a -0.94% move from the previous day.
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! It might be of some concern to shareholders to see the BioTelemetry, Inc. (NASDAQ:BEAT) share price down 15% in the l...